Cerebras Systems, the company behind the largest processor ever fabricated, is about to become the first pure-play AI chip maker to hit the public markets in 2026. In an amended registration statement filed with the SEC on May 4, the company set its IPO price range at $115 to $125 per share. At the top of that range, and based on the roughly 27.5 million Class A shares the company has indicated it plans to sell, the offering would raise approximately $3.4 billion and value Cerebras in the neighborhood of $14 billion on a fully diluted basis. The pricing signals strong demand from institutional investors eager for direct exposure to AI hardware beyond Nvidia.
The listing caps a turbulent journey. Cerebras first filed to go public in September 2024, but the offering stalled after U.S. regulators raised concerns about the company’s commercial ties to G42, the Abu Dhabi-based technology group. A national security review and subsequent restructuring of that relationship pushed the IPO into 2026. Now, with a freshly amended S-1, a revamped corporate charter, and a formal partnership with OpenAI on the books, Cerebras is moving fast to lock in a Nasdaq debut while appetite for AI infrastructure stocks remains intense.
The chip that defines the company
Cerebras’ entire thesis rests on a piece of silicon that looks nothing like a conventional processor. Its Wafer-Scale Engine 3 (WSE-3) occupies an entire 300mm wafer, roughly the size of a dinner plate, packing 4 trillion transistors and 44 gigabytes of on-chip SRAM. Where Nvidia’s flagship data-center GPUs are individual dies cut from a wafer and then networked together in clusters, Cerebras skips the cutting step entirely. The result is a single, massive chip purpose-built for the matrix math that underpins large language model training and, increasingly, inference.
That architectural bet is what separates Cerebras from every other company in the AI silicon market. Nvidia, AMD, Intel, and a growing roster of startups all compete on variations of the GPU or accelerator model. Cerebras is wagering that wafer-scale integration, despite its manufacturing complexity, delivers enough of a throughput and memory-bandwidth advantage to justify a premium price and a narrower customer base.
The OpenAI contract
Buried in the original S-1 filed on April 17 is Exhibit 10.11, a master relationship agreement between Cerebras and OpenAI OpCo, LLC, effective December 24, 2025. The contract covers services, governance committee mechanics, term and termination provisions, and a publicity clause allowing joint announcements. Cerebras filed it as a material exhibit, a designation that carries legal weight: management and counsel determined that omitting the agreement could mislead investors about the company’s commercial position.
What the exhibit does not reveal is equally important. Key commercial terms, including pricing, volume commitments, and any exclusivity provisions, appear to be redacted or summarized at a level that obscures the deal’s precise financial impact. Investors know that OpenAI is a marquee customer and that the relationship is formally structured. They do not yet know how much revenue it will generate, how long it will last in practice, or whether Cerebras faces concentration risk if OpenAI scales back orders or shifts workloads to in-house chips, a path OpenAI has publicly explored.
Corporate structure and governance
Ahead of the listing, Cerebras executed an amended and restated certificate of incorporation on January 28, 2026, included in the broader registration record. The charter establishes two share classes: Class A, which will trade publicly, and Class N, a supervoting class held by insiders. Conversion mechanics between the classes and preferred stock series designations are spelled out in the document.
Dual-class structures are standard among founder-led tech IPOs. Alphabet, Meta, and Snap all went public with similar arrangements. The practical effect is that CEO Andrew Feldman and other insiders will retain outsized voting control even as public shareholders supply capital. The specific conversion triggers and sunset provisions, if any, will determine how quickly that control dilutes over time. Investors who care about governance should read the charter closely before placing orders.
What investors still do not know
Several gaps remain in the public record. The amended S-1 tightens the price range but does not disclose the final underwriter allocation or the lock-up terms that will govern insider selling after the stock begins trading. Lock-up periods typically run 90 to 180 days, but the specific schedule matters: a short lock-up or a staggered release could create selling pressure just as the stock finds its footing.
Revenue visibility is another open question. The filings include material agreements and governance documents but no forward-looking revenue guidance tied to the OpenAI contract or other customers. Analyst estimates projecting 2026 growth have circulated in secondary coverage, but those figures rely on assumptions about fully diluted share counts, option pools, and contract ramp timelines that the filings alone do not confirm. Until Cerebras reports its first quarterly earnings as a public company, third-party revenue forecasts should be treated as directional, not definitive.
On the competitive front, independent, peer-reviewed benchmarks comparing the WSE-3 against Nvidia’s H100 or B200 GPUs have not appeared in the filing exhibits. Cerebras’ own white papers describe advantages in throughput and memory bandwidth, but standardized third-party testing data is absent from the SEC record. That does not mean the claims are wrong; it means they are unverified by an independent source investors can cite with confidence.
Timing, too, remains fluid. The tighter price range suggests the roadshow is either underway or imminent, but no specific listing date appears in the documents reviewed as of late May 2026. Market conditions for high-growth tech offerings can shift quickly, and Cerebras retains the flexibility to adjust pricing, sizing, or timing based on investor feedback. Until a final prospectus is filed and shares begin trading, all valuation and capital-raise figures are provisional.
What the SEC filings actually prove and what they leave open
Strip away the hype cycle and the analyst speculation, and the SEC record supports a narrow but solid set of facts. Cerebras is pursuing a Nasdaq listing at $115 to $125 per share. It has a formally acknowledged, legally material partnership with OpenAI. It has adopted a dual-class governance structure designed to keep founders in control. And it has moved from initial filing to amended pricing in roughly three weeks, a pace that suggests underwriter confidence and institutional interest.
What the filings do not prove is whether Cerebras can convert architectural novelty into durable revenue, defend its position against Nvidia’s ecosystem advantages and a wave of custom silicon from hyperscalers, or avoid the customer-concentration risk that comes with leaning heavily on a single blockbuster contract. Those answers will arrive in quarterly earnings reports, not registration statements.
For now, the verified record points to a company that has cleared the regulatory and structural hurdles to go public and is betting that investors will pay a premium for the only pure-play AI chip stock on the market. Whether that premium holds will depend on execution that no filing can guarantee.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
